Delivery Order SPE2DB20D1109-SPE2DB25FP42B
- Not listed
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on May 30, 2025, with a ceiling value of $5,701.69 and ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a procurement of emergency medical supplies critical to military healthcare operations. The contract was executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $5,099.81 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with performance completing by July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a contract ceiling value of $14,125.92 and an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a standard pharmaceutical procurement supporting federal medical supply chain requirements. The place of performance is listed as...
- The Defense Logistics Agency awarded a $3,626.12 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with completion scheduled for June 23, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,118.75 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2 pack) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $23,377.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $2,387.28 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires completion by July 21, 2025. The order was issued on July 18, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,780.42 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed from the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $1,209.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector packs (2-count). This competitively awarded, non-set-aside delivery order was issued on June 17, 2025, with an ultimate completion date of June 18, 2025, and operates under firm fixed pricing. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP42BDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,702.82 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle extending through December 2026. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement of critical emergency medical supplies supporting military healthcare operations. AmerisourceBergen Drug Corp, a major pharmaceutical and healthcare solutions distributor, maintains an extensive portfolio of federal contracts with DLA for diverse pharmaceutical products and medical supplies spanning multiple therapeutic categories. The delivery order leverages the broader IDC framework that enables AmerisourceBergen to supply medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. The contract carries no set-aside designation and reflects the contractor's established capability to meet federal procurement requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/18/25 |